23andMe Holding (MEUSW) Stock Analysis

What 23andMe Holding does

23andMe Holding Co. is a consumer-focused genetics and research firm that builds an extensive genetic database. This resource is designed to generate crucial insights, thereby accelerating the identification of novel targets for pharmaceutical development. The company provides a crowdsourced platform, enabling individuals to access, comprehend, and benefit from their genetic information. Through its direct-to-consumer genetic testing services, 23andMe delivers personalized reports covering genetic health predispositions, ancestral origins, and various inheritable traits. The organization was founded in 2006 and maintains its principal office in Sunnyvale, California, with an additional presence in Mountain View, California.

Key metrics

ETFs linked to MEUSW

Broad-market and Healthcare sector ETFs an investor holding 23andMe Holding is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how MEUSW fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Similar companies

Frequently asked questions

What is the ticker symbol for 23andMe Holding?

23andMe Holding trades under the ticker MEUSW on NASDAQ.

Which exchange is MEUSW listed on?

MEUSW is listed on NASDAQ.

What sector does 23andMe Holding operate in?

23andMe Holding is classified in the Healthcare sector (Medical - Diagnostics & Research industry).

How can PortView help analyze MEUSW in a portfolio?

PortView shows MEUSW's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.